16:00 17:15 hrs - Session 1 - Rare diseases and new approaches. Chair: Alexander Claviez (Kiel), Krzysztof Kalwak (Wroclaw)
|
|
|
- Kerrie Blair
- 5 years ago
- Views:
Transcription
1 9. June 2016 Friday afternoon (15:00-19:00 hrs) 15:45-16:00 hrs - Welcome address: Alicja Chybicka (Wrocław) Krzysztof Kalwak (Wroclaw) Meinolf Suttorp (Dresden) Petr Sedlacek (Prague) 16:00 17:15 hrs - Session 1 - Rare diseases and new approaches Chair: Alexander Claviez (Kiel), Krzysztof Kalwak (Wroclaw) - Carl Friedrich Classen (D) - confirmed Glioblastoma how to cure the (almost) incurable disease? New hints from the research. - Meinolf Suttorp (D)- confirmed Can we stop treatment in CML patients? - Alexander Claviez (D) - confirmed Brentuximab vedotin in the treatment of CD30+ HL and NHL.
2 17:15-17:45 hrs - Coffee Break 17:45 19:15 hrs - Session 2 - Acute lymphoblastic leukemia - Wojciech Młynarski- confirmed Chair: Bernd Gruhn (Jena), Meinolf Suttorp (Dresden) How to optimise the use of L-asparaginase? from bench to clinic and back - Marketa Zaliova- confirmed IKAROS and ERG mutations in ALL. Do they mean much? - Agata Pastorczak- confirmed Distinct clinical and biological features of acute lymphoblastic leukemia in patients with chromosomal instability syndromes. - Krzysztof Kalwak - confirmed Do we need to think about immunoglobulin substitution in children with leukemia and lymphoma and post HSCT? New drugs, new protocols brand new problems. from 19:30 hrs Networking Dinner
3 08:30 10:00 hrs - Session 3 - The broad field of pediatric stem cell transplantation - Petr Sedlacek(CZ)- confirmed Chair: Karl W. Sykora (Hannover), Jacek Wachowiak (Poznan) VOD should we use defibrotide prophylaxis or just save the precious drug for treatment only? - Peter Svec (SK)- confirmed Definition and therapy of TMA after HSCT - Krzysztof Kalwak(PL)- confirmed Haploidentical transplants in children: PTCY or T cell depleted - Catharina Schuetz (D)- confirmed Late effects of HSCT in SCID patients. Should we condition or not? 10:00-10:30 hrs - Coffee Break 10:30 12:00 hrs - Session 4 HSCT in non-malignant disorders - Jacek Wachowiak- confirmed Chair: Ursula Creutzig (Hannover), Petr Sedlacek (Prague) SAA/PNH whom and when to transplant? - Joern-Sven Kuehl- confirmed
4 Long follow up of patients with X-ALD posttransplant - Karl Walter Sykora- confirmed Current guidelines on SCT/ERT in metabolic disorders? 12:00-13:30 Lunch 18. June 2016 Saturday afternoon (13:30-18:00 hrs) 13:30 14:45 hrs - Session 5 - Acute myeloid leukemia - Ursula Creutzig - confirmed Chair: Ursula Creutzig (Munich), Dirk Reinhardt (Essen), CNS positive AML is there a problem? - Dirk Reinhardt - confirmed New drugs in the treatment of childhood AML - inquired - Ursula Creutzig- confirmed AML in Down Syndrome patients hrs. Session 6 Cord blood and Wharton s Jelly derived MSCs Chair: Petr Sedlacek (Prague), Krzysztof Kalwak (Wroclaw)
5 - Krzysztof Kalwak(PL) - confirmed CBT is there still a role for MSD or UD CBT in the era of haploidentical transplants? - Magdalena Chrościńska-Krawczyk(Lublin, PL)- confirmed Mesenchymal Stem Cells i.v. and i.t. in neurology Polish Experience 15:45-16:15 hrs - Coffee Break 16:15 18:00 hrs - Session 7: Pretty Kettle of Fish - Eine schöne Bescherung No to pięknie! - To je ale nadělení! Ez aztán szép kis meglepetés! - Čo sa to tu deje? Chair: Krzysztof Kalwak (Wroclaw), Meinolf Suttorp (Dresden) from 19:45 hrs - Outdoor dinner 19. June 2016 Sunday morning (09:00-12:30 hrs) 09:00 10:00 hrs - Session 8 Iron overload: Chair T.B.A. - Sabina Sufliarska-inquired
6 Iron overload in Slovakian SCT and hematooncological pts - Jowita Frączkiewicz- confirmed Which transplant patients are good candidates for iron chelation therapy? - Regine Grosse- inquired German guidelines on iron overload in pediatric hematooncological patients 10:00-11:00 hrs Session 9 - Infectious complications in pediatric hematooncology, Chair: T.B.A Topics: - Michał Matysiak confirmed, title T.B.A T.Ociepa (inquired) - Echinocandins are they all the same? N.Irga-Jaworska (inquired) - Antimold prophylaxis in pediatric patients a bless or curse? T.B.A. - New and old antifungal drugs how to deal with such a rich armamentarium? Coffee Break 11:30 12:30 hrs - Session 8: From bench and bedside Chair: Petr Sedlacek (Prague), Meinolf Suttorp (Dresden) Abstracts of young investigators selected for oral presentation
7 - Marek Ussowicz (PL) - confirmed Ataxia-Teleangiectasia is there a role for HSCT? Presentation of awards to best abstracts presenters and adjourn
PROGRAMME Final
PROGRAMME Final 15. 05. 2015 15:00 19:30 hrs 19. June 2015 Friday afternoon 15:00 Welcome addresses: Petr Sedlacek Krzysztof Kalwak Meinolf Suttorp (Prague) (Wroclaw) (Dresden) 15:30 17:15 Session I: Late
Hinterzartener Kreis der DFG für Krebsforschung. From Molecular Mechanisms to Cancer Therapy
Hinterzartener Kreis der DFG für Krebsforschung From Molecular Mechanisms to Cancer Therapy March 23 - March 26, 2017 Villa La Collina Cadenabbia (Co), Italy Program Committee Andreas Neubauer, Marburg
What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS
What are stem cells? Stem cells are often called MASTER CELLS, and form the foundation for your entire body as building blocks for the blood, immune system, tissue and organs. They can REPLICATE or REGENERATE
MUD SCT. Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University
MUD SCT Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University Outlines Optimal match criteria for unrelated adult donors Role of ATG in MUD-SCT Post-transplant
Summary. Olga Zając, Katarzyna Derwich, Katarzyna Stefankiewicz, Jacek Wachowiak. Rep Pract Oncol Radiother, 2007; 12(5):
Rep Pract Oncol Radiother, 2007; 12(5): 283-288 Preliminary Communication Received: 2007.03.27 Accepted: 2007.07.24 Published: 2007.10.18 Authors Contribution: A Study Design B Data Collection C Statistical
3 rd EBMT International Transplant Course
3 rd EBMT International Transplant Course 07 th 9 th September 2018, University of Barcelona, Faculty of Medicine Carrer de Casanova 143, 08036 Barcelona, Spain #EBMTITC18 EBMT International WELCOME It
International Meeting dedicated to the memory of Raisa Gorbacheva. HEMOPOIETIC STEM CELLS TRANSPLANTATION Saint-Petersburg, September 21-22, 2007
International Meeting dedicated to the memory of Raisa Gorbacheva HEMOPOIETIC STEM CELLS TRANSPLANTATION Saint-Petersburg, September 21-22, 2007 Preliminary program September 21 Friday 8.00-8.30 - registration
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy Program Committee Martin Schuler, Essen (Chair) Cathrin Brisken,
Overview of CML related sessions at 23 rd EHA Meeting in Stockholm
Overview of CML related sessions at 23 rd EHA Meeting in Stockholm Time slots Sessions Location June 14th (Thursday) 8.00 10.00 Satellite Symposium: Targeting the individual: Personalized treatment in
6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.
MASTERCLASS 6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY Held with the support of 11-16 June 2016 Berlin, Germany Chairs: A. Eggert, DE B. Morland, UK R. Riccardi, IT INTRODUCTION ESO and SIOP-Europe
SCIENTIFIC TIMETABLE SIOP 2015
SCIENTIFIC TIMETABLE SIOP 2015 September, 2015 WEDNESDAY, 7 TH OCTOBER 2015 / DAY 2 1.43 09:30 SIOP Committee 12:00 SIOP Essential Drugs Working 13:00 SIOP Work (Open) 14:00 Nurse Researchers 16:00 17:00
CRC 992 Symposium on Medical Epigenetics 2018
CRC 992 Symposium on Medical Epigenetics 2018 Monday, March 12 th Wednesday, March 14 th Agenda Lecture Hall Otto-Krayer-Haus Albertstr. 25 79104 Freiburg, Germany Day 1 Monday, March 12 th 2018, 14:30-19:30
TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital)
Legend: Keynote Educational Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite SIOPe GA SIOP ABM Late Breaker Session Networking
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Targeted Cancer Therapy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Targeted Cancer Therapy April 26-29, 2012 Villa La Collina Cadenabbia (Co), Italy Program Committee Cathrin Brisken, Lausanne (Chair)
Wojciech Nowak, Rector of the Jagiellonian University Medical College, Kraków (PL)
Chairs Jakub Kenig, Jagiellonian University Medical College, Kraków (PL) Riccardo A. Audisio, Whiston Hospital, University of Liverpool, Liverpool, (UK) Tomasz Grodzicki, Jagiellonian University Medical
What s a Transplant? What s not?
What s a Transplant? What s not? How to report the difference? Daniel Weisdorf MD University of Minnesota Anti-cancer effects of BMT or PBSCT [HSCT] Kill the cancer Save the patient Restore immunocompetence
October 17 20, 2018 New York City. An International Congress on Lymphoma, Myeloma, and Leukemia Disorders
An International Congress on Lymphoma, Myeloma, and Leukemia Disorders NEW DAY! New Approaches in Acute Leukemias and Hematologic Malignancies Wednesday, October 17 October 17 20, 2018 New York City lymphomaandmyeloma.com
SIOP. 7 TH ESO-SIOP EUROPE MASTERCLASS IN PaEDiatRic OncOlOGy June 2018 nauen Ot Groß Behnitz (Berlin area), Germany.
SIOP SIOP Europe the European Society for Paediatric Oncology 7 TH ESO-SIOP EUROPE MASTERCLASS IN PaEDiatRic OncOlOGy 16-21 June 2018 nauen Ot Groß Behnitz (Berlin area), Germany Chairs: S. Bielack, DE
Current Status of Haploidentical Hematopoietic Stem Cell Transplantation
Current Status of Haploidentical Hematopoietic Stem Cell Transplantation Annalisa Ruggeri, MD, PhD Hematology and BMT Unit Hôpital Saint Antoine, Paris, France #EBMTITC16 www.ebmt.org Hematopoietic SCT
5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow
5/9/2018 or Stem Cell Harvest Where we are now, and What s Coming AA MDS International Foundation Indianapolis IN Luke Akard MD May 19, 2018 Infusion Transplant Conditioning Treatment 2-7 days STEM CELL
HEMATOLOGY & BLOOD TRANSFUSION
The Ninth Regional Meeting of The Lebanese Society of HEMATOLOGY & BLOOD TRANSFUSION October 1-3, 2015 Hilton Metropolitan Hotel, Beirut-Lebanon CME CREDITS Welcome Letter Dear Colleagues, I am pleased
Stem Cell Transplantation
Stem Cell Transplantation Evelyne Willems Centre Hospitalier Universitaire, ULg, Liège Post-ASH meeting, January 11, 2012, Brussels Plan 1. Select the patient: validation of HCT-CI 2. Select the donor
Haploidentical Transplants for Lymphoma. Andrea Bacigalupo Universita Cattolica Policlinico Gemelli Roma - Italy
Haploidentical Transplants for Lymphoma Andrea Bacigalupo Universita Cattolica Policlinico Gemelli Roma - Italy HODGKIN NON HODGKIN Non Myelo Ablative Regimen Luznik L et al BBMT 2008 Comparison of Outcomes
Early diagnosis saves lives #SpotLeukaemia
Early diagnosis saves lives #SpotLeukaemia Leukaemia... is a blood cancer affects people of all ages Leukaemia symptoms are hard to spot, as they are similar to the symptoms of common, unrelated conditions.
Overview of CML related sessions at 21 th EHA Meeting in Copenhagen Preliminary Program
Overview of CML related sessions at 21 th EHA Meeting in Copenhagen Preliminary Program Time slots Sessions Location June 9 th (Thursday) 8.00 10.00 Satellite Symposium: Improving outcomes: individualising
Bone Marrow Transplantation in Myelodysplastic Syndromes. An overview for the Myelodysplasia Support Group of Ottawa
Bone Marrow Transplantation in Myelodysplastic Syndromes An overview for the Myelodysplasia Support Group of Ottawa Objectives Provide brief review of marrow failure Re emphasize the importance of predictions
LEUKEMIAS 2017 ACUTE & CHRONIC ENCORE AT WYNN LAS VEGAS LAS VEGAS, NEVADA OCTOBER 6 7, 2017
Jointly provided by Mayo School of Continuous Professional Development and Mayo Continuing Nursing Education ACUTE & CHRONIC LEUKEMIAS 2017 REGISTER NOW! $75 DISCOUNT For Early Registration Expires 9/6/2017
Program General Session Room is Val Verde
Friday, September 28, 2018 11:30 AM - 12:20 PM Lunch with the Faculty AST Fellows Symposium on Transplantation September 28-30, 2018 Hilton DFW Lakes Executive Conference Center Grapevine, TX Program General
Case-Control Study: ABO-Incompatible Plasma Causing Hepatic Veno-Occlusive Disease in HSCT
Case-Control Study: ABO-Incompatible Plasma Causing Hepatic Veno-Occlusive Disease in HSCT Erin Meyer, DO, MPH Assistant Medical Director of Blood, Tissue, and Apheresis Services Children s Healthcare
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy Program Committee Ursula Klingmüller, Heidelberg (Chair)
What s new in Blood and Marrow Transplant? Saar Gill, MD PhD Jan 22, 2016
What s new in Blood and Marrow Transplant? Saar Gill, MD PhD Jan 22, 2016 Division of Hematology-Oncology University of Pennsylvania Perelman School of Medicine 1 Who should be transplanted and how? Updates
Le infezioni fungine nel trapianto di cellule staminali emopoietiche. Claudio Viscoli Professor of Infectious Disease University of Genova, Italy
Le infezioni fungine nel trapianto di cellule staminali emopoietiche Claudio Viscoli Professor of Infectious Disease University of Genova, Italy Potential conflicts of interest Received grants as speaker/moderator
Atul Humar, MD, MSc Director, Transplant Program, University Health Network, University of Toronto
TIME PROGRAM TITLE 7:30 8:15 Registration and Continental Breakfast 8:15 8:30 Welcoming Remarks TOPIC: VIRUSES Session Chair: Shahid Husain CMV: What is New, What s Hot Atul Humar, MD, MSc Director, Transplant
THE ROLE OF TBI IN STEM CELL TRANSPLANTATION. Dr. Biju George Professor Department of Haematology CMC Vellore
THE ROLE OF TBI IN STEM CELL TRANSPLANTATION Dr. Biju George Professor Department of Haematology CMC Vellore Introduction Radiotherapy is the medical use of ionising radiation. TBI or Total Body Irradiation
Annual Conference of the Canadian Blood and Marrow Transplant Group. June 11 to 14, 2014 The Westin Nova Scotian 1181 Hollis Street Halifax, NS
Annual Conference of the Canadian Blood Preliminary Program In conjunction with the Canadian National, Canadian Apheresis Group, Society, and Vector CBMTG Head Office Malachite Management Inc 375 West
International Course in Contrast Enhanced Ultrasound
International Course in Contrast Enhanced Ultrasound Part I: Liver, Gallbladder, Pancreas & Kidney Course Director: HP Weskott 9th - 12th October 2014 Hannover - Germany Dear colleagues, Like no other
High risk non-muscle invasive bladder cancer: From guidelines to future approaches Chairs: A. Lopez Beltran, Lisbon (PT)
Friday, 8 June 2018 EAU Update on Bladder Cancer (BCa18) Challenging your knowledge of the EAU Guidelines 8-9 June 2018, Munich, Germany Steering committee: F. Montorsi, H. Van Poppel and M. Wirth Scientific
TUESDAY, 18th OCTOBER, 2016 / DAY -2
Legend: Keynote Educational PODC Symposium Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite Symposium SIOPe GA SIOP ABM Late
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme 14-19 July 2016, Valencia, Spain Co-chairs: Andrés Cervantes, ES - Nicholas Pavlidis, GR - Susana Banerjee, UK Thursday, 14
Samples Available for Recipient Only. Samples Available for Recipient and Donor
Unrelated HCT Research Sample Inventory - Summary for First Allogeneic Transplants in CRF and TED with biospecimens available through the CIBMTR Repository stratified by availability of paired samples,
Systematic Reviews in Hematological Malignancies
Systematic Reviews in Hematological Malignancies Pia Raanani, MD Davidoff Cancer Center Rabin Medical Center, Israel 1 2 Disorder CHMG Systematic review* Title Protocol Full Review Myelodysplastic syndrome
Primary prophylaxis of invasive fungal infection in patients with haematological diseases
Primary prophylaxis of invasive fungal infection in patients with haematological diseases Tunis, May 24 2012 Important questions for antifungal prophylaxis Who are the patients at risk? Which is the risk:
The Blood and Marrow. Transplant Program at Northside Hospital 30%
IN THIS ISSUE: SPRING 12 www.bmtga.com www.northside.com The Blood and Marrow News Transplant Program at Northside Hospital Research Updates HLA-identical Relatives are Suitable Alternative Donors for
Disclosures of: Emanuele Angelucci
Company name Novartis Disclosures of: Emanuele Angelucci Research support Employee Consultant Stockholder Speakers bureau Advisory board Chair of TELESTO pro Other EBMT 2012 Educational Session Haemoglobinopathy
Past Chapter Summaries Educational Topics Summary
Below is a comprehensive summary of all of the different Educational Topics our Local Chapters have presented and/or provided 2014 1. The most powerful force in nursing 2. Hope and meaning in life in adolescent
The future of HSCT. John Barrett, MD, NHBLI, NIH Bethesda MD
The future of HSCT John Barrett, MD, NHBLI, NIH Bethesda MD Transplants today Current approaches to improve SCT outcome Optimize stem cell dose and source BMT? PBSCT? Adjusting post transplant I/S to minimize
An Introduction to Bone Marrow Transplant
Introduction to Blood Cancers An Introduction to Bone Marrow Transplant Rushang Patel, MD, PhD, FACP Florida Hospital Medical Group S My RBC Plt Gran Polycythemia Vera Essential Thrombocythemia AML, CML,
Samples Available for Recipient and Donor
Unrelated HCT Research Sample Inventory - Summary for First Allogeneic Transplants in CRF and TED with biospecimens available through the CIBMTR Repository stratified by availability of paired samples,
Samples Available for Recipient Only. Samples Available for Recipient and Donor
Unrelated HCT Research Sample Inventory - Summary for First Allogeneic Transplants in CRF and TED with biospecimens available through the CIBMTR Repository stratified by availability of paired samples,
PROGRAMME ATAXIA-TELANGIECTASIA CLINICAL REASERCH CONFERENCE
PROGRAMME ATAXIA-TELANGIECTASIA REASERCH CONFERENCE WARSAW, POLAND 6-8 October, 2016 Page 1 of 7 Thursday 6 October 12:00-13:00 Lunch 13:00 WELCOME Barbara Pietrucha and William Davis 13.10 Welcome from
Specific Cancer Diagnosis. Age Range France No 149 NR NHL Cancer NA Chemo COPADM
APPENDIX 11: RANDOMIZED CONTROLLED TRIALS OF ANY INTERVENTION FOR THE PREVENTION OF ORAL MUCOSITIS IN PEDIATRIC PATIENTS RECEIVING TREATMENT FOR CANCER OR UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Need considerable resources material and human.
TRAN VAN BINH INTRODUCTION Hematopoietic Stem cell transplantation: the best way to manage Malignancies and non Malignant blood disorders. Need considerable resources material and human. In developping
Twenty-five-years history of the Department of Immunology at the Children s Memorial Health Institute in Warsaw
Immunological forum Twenty-five-years history of the Department of Immunology at the Children s Memorial Health Institute in Warsaw EWA BERNATOWSKA This year the Department of Immunology at the Children
4TH INTERNATIONAL PATIENT AND PHYSICIAN SUMMIT ON WALDENSTROM S MACROGLOBULINEMIA MARCH 10-13, 2011, ORLANDO, FL, USA
4TH INTERNATIONAL PATIENT AND PHYSICIAN SUMMIT ON WALDENSTROM S MACROGLOBULINEMIA MARCH 10-13, 2011, ORLANDO, FL, USA Thursday, March 10, 2010 Buena Vista Palace Hotel 3:00 PM to 6:00 PM Registration (Hampton
21 st ANNUAL CLINICAL CYTOMETRY MEETING AND COURSE. LONG BEACH, California October 6-10, 2006 PRELIMINARY PROGRAM
CCS 21 st 1 ANNUAL MEETING 1 21 st ANNUAL CLINICAL CYTOMETRY MEETING AND COURSE LONG BEACH, California October 6-10, 2006 PRELIMINARY PROGRAM For more information visit www.cytometry.org 2 CCS 21 st ANNUAL
The EUTOS Long-Term Survival score was tested in 350 children
ARTICLE Chronic Myeloid Leukemia EUROPEAN HEMATOLOGY ASSOCIATION Ferrata Storti Foundation Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic
EBMT ADWP/IEWP. 3 rd 5 th November 2017 Newcastle, UK IEWP Chairman: A Lankester IEWP Secretary: M Albert. Local Chair: A Gennery
EBMT ADWP/IEWP 3 rd 5 th November 2017 Newcastle, UK IEWP Chairman: A Lankester IEWP Secretary: M Albert ADWP Chairman: J Snowden ADWP Secretary: T Alexander Local Chair: A Gennery Telephone: +44 (0)191
Disclosers Updates: Management of Aplastic Anemia and Congenital Marrow Failure 5/9/2017
2017 Updates: Management of Aplastic Anemia and Congenital Marrow Failure Sachit Patel, MD Department of Pediatrics Division of Hematology-Oncology Blood and Marrow Transplantation Disclosers None 1 Objectives:
PRELIMINARY PROGRAMME. 5 edition BERLIN ORGANISING SECRETARIAT
PRELIMINARY PROGRAMME th BERLIN 20-23 JUNE 2019 ORGANISING SECRETARIAT th SCIENTIFIC ORGANIZATION SPAO Sociedad de Pediatría de Andalucía Oriental y Extremadura PATRONEGE BERLIN 20-23 JUNE 2019 COMMITTEES
The Immunobiology Working Party
The Immunobiology Working Party Educational Event 28-29 September 2013,, Italy Faculty of Medicine, University of Chairman: Andrea Velardi I am happy to announce the upcoming EBMT Immunobiology Working
Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW
PRELIMINARY PROGRAM (all academic titles have been omitted) Thursday, June 21, 2018 3.30 p.m. Start of the conference OPENING ADDRESSES Wilhelm Krull, Volkswagen Foundation, Germany Christopher Baum, Medical
EACS HIV Summer School PRELIMINARY PROGRAMME
EACS HIV Summer School Thursday, August 30, 2018 Monday, September 3, 2018 Montpellier, France This 5-day residential course is designed for clinicians experienced in HIV management who want an update
Preliminary Program CALGARY, AB JUNE 5-8, 2019 ANNUAL CONFERENCE OF THE CANADIAN BLOOD AND MARROW TRANSPLANT GROUP
CALGARY, AB JUNE 5-8, Preliminary Program CALGARY, AB JUNE 5-8, TRANSPLANT : MOVING BEYOND TOXICITY PRE-CONFERENCE DAY WEDNESDAY, JUNE 5, 10:30am 4:00pm 12:15pm 1:30pm 4:00pm 4:30pm 4:30pm 7:00pm 7:00pm
Relapse After Transplant: Next Steps for Patients with Hodgkin Lymphoma
Hi! My name is Alison Moskowitz. I am an attending at Memorial Sloan Kettering Cancer Center within the Lymphoma Department. I am speaking on behalf of ManagingHodgkinLymphoma.com. I will be discussing
Department of Pediatric Hematology/Oncology, University Children s Hospital Tübingen, Hoppe-Seyler-Strß 1, Tübingen, Germany 2
Case Reports in Transplantation Volume 2012, Article ID 672923, 4 pages doi:10.1155/2012/672923 Case Report Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem
املؤمتر الدويل الرابع لجمعية امراض الدم األردنية
The 4 th International Conference of the Jordanian Society of Hematology املؤمتر الدويل الرابع لجمعية امراض الدم األردنية Jordanian Society of Hematology February 10 th - 12 th, 2016 Le Royal Hotel Amman,
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition SIXTH DRAFT OF THE PROGRAM AUGUST 28, 2014 Wednesday, October 5, 2016 08:00-16:30 Post Graduate course (To be developed by the
ESSD EUROPEAN SOCIETY FOR SOCIAL DRUG RESEARCH. 28th ANNUAL CONFERENCE LISBON, SEPTEMBER 2017 PROGRAMME
ESSD EUROPEAN SOCIETY FOR SOCIAL DRUG RESEARCH 28th ANNUAL CONFERENCE LISBON, 21-23 SEPTEMBER 2017 PROGRAMME HOSTED BY CIES-IUL, Centre for Research and Studies in Sociology, University Institute of Lisbon
Personalized Therapy for Acute Myeloid Leukemia. Patrick Stiff MD Loyola University Medical Center
Personalized Therapy for Acute Myeloid Leukemia Patrick Stiff MD Loyola University Medical Center 708-327-3216 Major groups of Mutations in AML Targets for AML: Is this Achievable? Chronic Myeloid Leukemia:
Haploidentical Transplantation: The Answer to our Donor Problems? Mary M. Horowitz, MD, MS CIBMTR, Medical College of Wisconsin January 2017
Haploidentical Transplantation: The Answer to our Donor Problems? Mary M. Horowitz, MD, MS CIBMTR, Medical College of Wisconsin January 2017 Allogeneic Transplant Recipients in the US, by Donor Type 9000
LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University
LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish
SICKLE CELL DISEASE TO TREAT OR
SICKLE CELL DISEASE TO TREAT OR NOT TO TREAT COHEM Barcelona September 8, 2012 Sujit Sheth, M.D. Pediatric Hematology Oncology Disclosures None Outline Morbidity and mortality Definitive therapies Risk
LONG TERM FOLLOW-UP OF PATIENTS WITH FANCONI ANEMIA AFTER ALLOGENEIC T-CELL DEPLETED HEMATOPOITEIC STEM CELL TRANSPLANTATION FROM ALTERNATIVE DONORS
LONG TERM FOLLOW-UP OF PATIENTS WITH FANCONI ANEMIA AFTER ALLOGENEIC T-CELL DEPLETED HEMATOPOITEIC STEM CELL TRANSPLANTATION FROM ALTERNATIVE DONORS Farid Boulad, Susan E Prockop, Praveen Anur, Danielle
Human Herpes Virus-6 Limbic Encephalitis
Case Studies [1] March 19, 2013 Case history: A 32-year-old Caucasian female with newly diagnosed acute myeloid leukemia (AML) was treated with induction chemotherapy and attained complete remission. She
Elisabeth Koller 3rd Medical Dept., Center for Hematology and Oncology, Hanusch Hospital, Vienna, Austria
Elisabeth Koller 3rd Medical Dept., Center for Hematology and Oncology, Hanusch Hospital, Vienna, Austria Incidence Diagnosis Prognostic factors Treatment Induction therapy - HSCT Indications for HSCT
Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia
(2005) 19, 2117 2124 & 2005 Nature Publishing Group All rights reserved 0887-6924/05 $30.00 www.nature.com/leu Twenty years of Polish experience with three consecutive protocols for treatment of childhood
Myelodyplastic Syndromes Paul J. Shami, M.D.
Myelodyplastic Syndromes Paul J. Shami, M.D. Professor of Hematology, University of Utah Member, Huntsman Cancer Institute Objectives Define Myelodysplastic Syndromes (MDS) Explain how MDS are diagnosed
Clinical Breakthroughs & Challenges In Hematologic Malignancies
Clinical Breakthroughs & Challenges In Hematologic Malignancies Saturday, January 19, 2013 Disney s Grand Floridian Resort Lake Buena Vista, Florida COURSE DIRECTOR CONFERENCE CONTACT Melissa.Pearson@Moffitt.org
Stem Cells And The Future of Regenerative Medicine. Dipnarine Maharaj, M. D., FACP
Stem Cells And The Future of Regenerative Medicine Dipnarine Maharaj, M. D., FACP The following potential conflict of interest relationships are germane to my presentation. Employment: South Florida Bone
Fall 2018: Spring 2019:
Fall 2018: Fall 2018 Opening Weekend Fall Break 2018 Thanksgiving Break 2018 Finals Week Fall 2018 Winter Break 2018 Spring 2019: Spring 2019 Opening Weekend Spring Break 2019 Easter Break 2019 Finals
12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization
Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,
4nd Patient and Family Day
4nd Patient and Family Day EBMT Slide template Barcelona 7 February 2008 EBMT 2010 Vienna, Austria ; www.ebmt.org History of Stem Cell Transplantation Appelbaum et al, NEJM 2006 What is EBMT? Scientific,
Saturday 8/26/2017 7:00am - 7:00pm Closed 11:00am - 9:00pm Closed Closed
Fall 2017 Opening Weekend Friday 8/25/2017 7:00am - 7:00pm Closed 8:30am - 2:00pm Closed Closed Saturday 8/26/2017 7:00am - 7:00pm Closed 11:00am - 9:00pm Closed Closed Sunday 8/27/2017 7:30 am - 2:00
Johann Hitzler, MD, FRCPC, FAAP Jacqueline Halton, MD, FRCPC Jason D. Pole, PhD
Photo by Tynan Studio Johann Hitzler, MD, FRCPC, FAAP Jacqueline Halton, MD, FRCPC Jason D. Pole, PhD 96 Atlas of Childhood Cancer in Ontario (1985-2004) Chapter 6: Leukemia 6 Leukemia Atlas of Childhood
The National Marrow Donor Program. Graft Sources for Hematopoietic Cell Transplantation. Simon Bostic, URD Transplant Recipient
1988 199 1992 1994 1996 1998 2 22 24 26 28 21 212 214 216 218 Adult Donors Cord Blood Units The National Donor Program Graft Sources for Hematopoietic Cell Transplantation Dennis L. Confer, MD Chief Medical
EBV in HSCT 2015 update of ECIL guidelines
ECIL-6 EBV in HSCT 2015 update of ECIL guidelines Jan Styczynski (Poland, chair), Walter van der Velden (Netherlands), Christopher Fox (United Kingdom), Dan Engelhard (Israel), Rafael de la Camara (Spain),
SPINAL CORD INJURY SUMMIT. May 19-20, The Ohio State University Neurological Institute -
SPINAL CORD INJURY SUMMIT May 19-20, 2017 - The Ohio State University Neurological Institute - Meeting Venue: Ross Auditorium, Ross Heart Hospital, 452 W 12 th Ave, Columbus. Hotel: Homewood Suites, 1576
LEUKEMIA AND LYMPHOMA
J O N AT H A N W O O D & A S S O C I A T E S An MDedge Company LEUKEMIA AND LYMPHOMA Europe and the US Linking Knowledge and Practice 3-5 October 2018 DUBROVNIK Valamar Lacroma Dubrovnik Hotel Dubrovnik,
Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW
PRELIMINARY PROGRAM (all academic titles have been omitted) Thursday, June 21, 2018 3.30 p.m. Start of the conference OPENING ADDRESSES Wilhelm Krull, Volkswagen Foundation, Germany Christopher Baum, Medical
Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen
Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells
Reduced-intensity Conditioning Transplantation
Reduced-intensity Conditioning Transplantation Current Role and Future Prospect He Huang M.D., Ph.D. Bone Marrow Transplantation Center The First Affiliated Hospital Zhejiang University School of Medicine,
16 TH -17 TH INNOVATIONS IN ONCOLOGY NOVEMBER HEIDELBERG
16 TH -17 TH 2015 NOVEMBER INNOVATIONS IN ONCOLOGY HEIDELBERG INNOVATIONS IN ONCOLOGY HEIDELBERG, NOVEMBER 16 TH - 17 TH 2015 German Cancer Research Center (DKFZ) Heidelberg - Germany Hosted by the National
Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017
Overview of Aplastic Anemia Overview of Aplastic Anemia Peter Westervelt, MD, PhD Professor of Medicine Chief, BMT/Leukemia Section Washington University School of Medicine Epidemiology Normal hematopoiesis
Bosulif. Bosulif (bosutinib) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.22 Section: Prescription Drugs Effective Date: April 1,2018 Subject: Bosulif Page: 1 of 5 Last Review
Recommended Timing for Transplant Consultation
REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org
Principles of Spine Fracture Management
EUROPE Course program Principles of Spine Fracture Management April, 6-7, 2018 Ostróda, Poland 2 Principles of Spine Fracture Management Dear Colleagues, As we all know, on-going education plays a critical
Dr. Joseph McGuirk Professor of Medicine, BMT Medical Director, Interim Director, Division of Hematology/Oncology
Advances in Autologous and Allogeneic Stem Cell Transplantation Dr. Joseph McGuirk Professor of Medicine, BMT Medical Director, Interim Director, Division of Hematology/Oncology April 12, 2014 Disclosures
PancreasFest 2015 Schedule ASBMT Fall Clinical Education Conference
The Fred Hutch BMT Program at Seattle Cancer Care Alliance presents The 4th Annual ASBMT Fall Clinical Education Conference Thursday, October 26 Saturday, October 28, 2017 Sheraton Hotel, Seattle, WA Register
Acute myeloid leukemia: prognosis and treatment. Dimitri A. Breems, MD, PhD Internist-Hematoloog Ziekenhuis Netwerk Antwerpen Campus Stuivenberg
Acute myeloid leukemia: prognosis and treatment Dimitri A. Breems, MD, PhD Internist-Hematoloog Ziekenhuis Netwerk Antwerpen Campus Stuivenberg Patient Female, 39 years History: hypothyroidism Present: